Toward Bicalutamide Analogues with High Structural Diversity Using Catalytic Asymmetric Oxohydroxylation

Area of Science:

• Organic Chemistry
• Medicinal Chemistry
• Catalysis

Background:

• Bicalutamide is a vital anti-androgen medication for prostate cancer treatment.
• Developing diverse bicalutamide analogues is crucial for improving efficacy and overcoming resistance.
• Efficient and enantioselective synthetic routes are needed for novel drug discovery.

Purpose of the Study:

• To develop a novel catalytic enantioselective synthesis for bicalutamide derivatives.
• To create a versatile route for generating structurally diverse analogues.
• To facilitate structure-activity relationship studies for prostate cancer drug development.

Main Methods:

• Asymmetric oxohydroxylation of alkenes using potassium permanganate.
• Cinchoninium-based organocatalysis for enantioselective induction.
• Synthesis of key α-hydroxy-β-keto ester intermediates.

Main Results:

• Efficient construction of α-hydroxy-β-keto esters achieved.
• High yields and excellent enantioselectivity demonstrated.
• Successful synthesis of diverse bicalutamide analogues.

Conclusions:

• A novel, efficient, and enantioselective synthetic route to bicalutamide derivatives was established.
• The method enables the creation of structurally diverse analogues for SAR studies.
• This approach holds promise for advancing prostate cancer drug development.